Literature DB >> 17703746

Investigation on the absorption kinetics of chlorogenic acid in rats by HPLC.

Jing Ren1, Xuehua Jiang, Chenrui Li.   

Abstract

Chlorogenic acid (ChA), a major phenolic compound in the Flos Lonicerae, is widely used in the traditional Chinese medicine practice. The purpose of this study is to report the pharmacokinetic parameters of ChA in rats after oral administration and explore its absorption profile briefly. A two-compartment model was proposed and validated through the program to explain the apparent triphasic phenomenon of ChA in rats after intragastric administration. A rapid absorption and a relatively slow distribution followed by a slower elimination phase were observed. At the administered doses of 200, 400 and 600 mg/kg, the values of absorption half-life (t 1/2 Ka) were 10.23, 18.66 and 28.13 min. The values of distribution half-life (t1/2) were 12.35, 31.04 and 39.19 min. And the values of elimination half-life (t1/2P) were 231.64, 337.23 and 420.81 min. The volume of distribution at the three doses were 55.26, 35.56, 32.22 L/kg, respectively. The AUC0-->infinity (area under the concentration-time curve) was not proportional to the administered dose. In the range of the doses examined, the absorption pharmacokinetics of ChA in rats was based on nonlinear kinetics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703746     DOI: 10.1007/bf02978845

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  2 in total

1.  Comparative pharmacokinetics of chlorogenic acid after oral administration in rats.

Authors:  Wei Qi; Ting Zhao; Wen-Wen Yang; Guang-Hou Wang; Hua Yu; Hai-Xiao Zhao; Chen Yang; Li-Xin Sun
Journal:  J Pharm Anal       Date:  2011-11-06

2.  Comparative pharmacokinetics of chlorogenic acid in beagles after oral administrations of single compound, the extracts of Lonicera japanica, and the mixture of chlorogenic acid, baicalin, and Forsythia suspense.

Authors:  Rong Liu; Ke Lai; Yu Xiao; Jing Ren
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.